Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-20

Clinical Trial Update: Clinical Study of the Effectiveness, Tolerability and Safety of the Drug "Anti-spike, Gel, 100 g in Bottles in Package No. 1" Produced by the Republican Unitary Enterprise "Unitekhprom BSU", With a Single Intraperitoneal Use After Surgery in Adult Patients With Acute Phlegmonous Appendicitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of Anti-spike Gel (100 g in bottles, Package No. 1) used intraperitoneally after surgery in adults with acute appendicitis; status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anti-spike, Gel, 100 g in Bottles in Package No. 1 (anti-spike gel)

Snippet

Sponsor: Research Institute for Physical Chemical Problems of the Belarusian State University | Conditions: Abdominal Adhesions | Phase 2 | Status: ACTIVE_NOT_RECRUITING